Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial data.

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...

Brace yourselves, Ozempic and Zepbound. Eli Lilly just released a jaw-dropping sneak peek from the final phases of testing for retatrutide (nicknamed "Reta"), a brand new GLP-1 weight loss drug that ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

What started with Ozempic has become a new era in weight-loss success with blockbuster GLP-1 drugs like Wegovy and Zepbound helping fight obesity. But they’re just the beginning. New treatments that ...

University of Maryland Medical System surgeons break down how weight loss surgery works, who qualifies and what patients can ...

This article was reviewed by Darragh O’Carroll, MD. Between considering nutrition, exercise, and perhaps even some supplements, a weight loss journey can feel like navigating a complex maze.

Intermittent fasting might not work for weight loss — these are the diets that do - As new research highlights the shortfalls ...

Medical weight loss is a personalized, medically supervised approach that goes beyond diet and exercise to address biological, hormonal, and behavioral factors affecting weight. Prescription weight ...